Mediwound LtdNASDAQ:MDWD
- LAST PRICE18.2400
- TODAY'S CHANGE (%)0.5800 (3.2843%)
- Bid / Lots18.1500/ 10
- Ask / Lots19.2000/ 3
- Open / Previous Close17.8300 / 17.6600
- Day Range
- 52 Week Range
- Volume73,119
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDWD |
|---|---|---|
| 09:32 ET | 100 | 17.83 |
| 09:36 ET | 300 | 17.82 |
| 09:38 ET | 300 | 17.67 |
| 09:39 ET | 206 | 17.66 |
| 09:43 ET | 3150 | 17.7 |
| 09:48 ET | 200 | 17.72 |
| 09:50 ET | 340 | 17.8 |
| 09:59 ET | 100 | 17.74 |
| 10:08 ET | 280 | 17.86 |
| 10:24 ET | 175 | 17.9001 |
| 10:28 ET | 349 | 17.9 |
| 10:30 ET | 1190 | 17.98 |
| 10:33 ET | 2382 | 18.15 |
| 10:42 ET | 933 | 18.16 |
| 10:48 ET | 150 | 18.18 |
| 10:55 ET | 100 | 18.1762 |
| 11:04 ET | 212 | 18.11 |
| 11:08 ET | 1320 | 18.165 |
| 11:09 ET | 704 | 18.27 |
| 11:13 ET | 285 | 18.45 |
| 11:22 ET | 100 | 18.44 |
| 11:31 ET | 414 | 18.37 |
| 11:36 ET | 100 | 18.38 |
| 11:42 ET | 463 | 18.44 |
| 11:44 ET | 786 | 18.38 |
| 11:51 ET | 300 | 18.28 |
| 11:54 ET | 600 | 18.26 |
| 12:00 ET | 300 | 18.26 |
| 12:05 ET | 300 | 18.3 |
| 12:16 ET | 10374 | 18.26 |
| 12:21 ET | 1326 | 18.2999 |
| 12:41 ET | 749 | 18.4899 |
| 12:43 ET | 740 | 18.43 |
| 12:50 ET | 535 | 18.35 |
| 12:52 ET | 475 | 18.3 |
| 01:03 ET | 10209 | 18.29 |
| 01:06 ET | 700 | 18.39 |
| 01:12 ET | 114 | 18.38 |
| 01:14 ET | 450 | 18.5 |
| 01:24 ET | 100 | 18.395 |
| 01:26 ET | 100 | 18.41 |
| 01:32 ET | 609 | 18.45 |
| 01:46 ET | 300 | 18.42 |
| 02:00 ET | 100 | 18.465 |
| 02:06 ET | 300 | 18.41 |
| 02:15 ET | 473 | 18.37 |
| 02:29 ET | 1250 | 18.3792 |
| 02:33 ET | 100 | 18.3 |
| 02:44 ET | 128 | 18.345 |
| 02:56 ET | 100 | 18.39 |
| 03:09 ET | 100 | 18.45 |
| 03:14 ET | 3671 | 18.445 |
| 03:16 ET | 300 | 18.4 |
| 03:25 ET | 100 | 18.45 |
| 03:30 ET | 100 | 18.45 |
| 03:32 ET | 100 | 18.44 |
| 03:39 ET | 100 | 18.49 |
| 03:43 ET | 659 | 18.465 |
| 03:45 ET | 3362 | 18.405 |
| 03:48 ET | 400 | 18.36 |
| 03:50 ET | 200 | 18.3635 |
| 03:52 ET | 652 | 18.26 |
| 03:54 ET | 400 | 18.255 |
| 03:56 ET | 100 | 18.26 |
| 03:57 ET | 443 | 18.19 |
| 03:59 ET | 1721 | 18.24 |
Apr 25, 2024
MediWound to Present New Data from EscharEx(R) Phase II Studies at Three Leading Wound Care Conferences, from 8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mediwound Ltd | 167.6M | -23.8x | --- |
Capricor Therapeutics Inc | 162.2M | -6.2x | --- |
ProQR Therapeutics NV | 159.5M | -5.2x | --- |
Cellectis SA | 182.7M | -1.3x | --- |
Uniqure NV | 217.2M | -0.7x | --- |
Adagene Inc | 103.8M | -5.5x | --- |
Company Information
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Contact Information
- Headquarters
- 42 Hayarkon StreetYAVNE, Israel 8122745
- Phone
- ---
- Fax
- ---
Executives
- Independent executive Chairman of the board
- Stephen Wills
- Chief Executive Officer
- Sharon Malka
- Chief Financial Officer
- Boaz Gur-Lavie
- Chief Operating Officer, Chief Compliance Officer
- Shmulik Hess
- Executive Vice President, General Counsel, Corporate Secretary
- Yaron Meyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $167.6M |
|---|---|
Revenue (TTM) | $18.7M |
Shares Outstanding | 9.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-0.77 |
Book Value | $3.43 |
P/E Ratio | -23.8x |
Price/Sales (TTM) | 9.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
